(Total Views: 111)
Posted On: 09/26/2023 12:35:47 PM
Post# of 58
$ABEO News Article - Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa https://marketwirenews.com/news-releases/abeo...78301.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
